⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 18, 2016NAM Perspectives

Real-World Evidence to Guide the Approval and Use of New Treatments

Steven K. Galson Gregory E. Simon

View at Publisher

Ask AI

Bookmark

Share

Abstract

Current State The Focus of Traditional Evidence Generation on Narrow Questions Regarding Efficacy and Safety Research regarding new treatments (drugs, biological products, and high-risk devices) often begins with a broad […]

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Galson et al. (2016) studied this question.

synapsesocial.com/papers/6a89add80e1a8f7244fd551d https://doi.org/10.31478/201610b

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Shared Commitments for Health and Health Care: A Trust Framework from the Learning Health SystemNAM Perspectives · Mon,
2Opportunities for Strengthening Climate Education for Clinical Health ProfessionalsNAM Perspectives · Fri,
3Pediatric Disaster Science: Understanding Needs, Highlighting Imperatives, and Leveraging OpportunitiesNAM Perspectives · Fri,
4Three Climate and Health Lessons from Nepal Ahead of COP28NAM Perspectives · Tue,
5Crossing the Decarbonization Chasm: A Call to Action for Hospital and Health System Leaders to Reduce Their Greenhouse Gas EmissionsNAM Perspectives · Tue,

More from NAM Perspectives

Systems Thinking for Public Health: A Case Study Using U.S. Public EducationTue,
Vital Signs for Pediatric Health: Chronic AbsenteeismMon,
A Penny for Your Thoughts? Moving Research Payment Transparency from Idiom to PolicyWed,
Achieving Oral Health for All through Public Health Approaches, Interprofessional, and Transdisciplinary EducationMon,
Health Technology for All: An Equity-Based Paradigm Shift OpportunityTue,